Provided by Tiger Fintech (Singapore) Pte. Ltd.

BioNTech SE

104.00
+1.981.94%
Pre-market: 104.350.3500+0.34%07:31 EDT
Volume:2.24M
Turnover:235.55M
Market Cap:24.96B
PE:-36.26
High:108.79
Open:107.64
Low:103.50
Close:102.02
Loading ...

Warburg Research Remains a Buy on SAP SE (0NW4)

TIPRANKS
·
23 Apr

Commentary: High-profile pneumonia deaths highlight the threat of respiratory infections

CNA
·
23 Apr

FACTBOX-European companies cut jobs as economy slows

Reuters
·
22 Apr

BioNTech to Report First Quarter 2025 Financial Results and Corporate Update on May 5, 2025

GlobeNewswire
·
22 Apr

BioNTech SE (BNTX) Q4 2024 Earnings Call Highlights: Navigating Challenges and Advancing Innovations

GuruFocus.com
·
22 Apr

European Equities Traded in the US as American Depositary Receipts Drop in Monday Trading

MT Newswires Live
·
21 Apr

Press Release: Invivyd Announces $30M Non-dilutive Loan Facility with Silicon Valley Bank

Dow Jones
·
21 Apr

Private credit needs to lift its game to be taken seriously

The Australian Financial Review
·
21 Apr

3 Magnificent Stocks to Buy That Are Near 52-Week Lows

Motley Fool
·
19 Apr

Nexus AG Discloses Manager’s Share Sale

TIPRANKS
·
17 Apr

BioNTech Se : Leerink Partners Cuts Target Price to $112 From $121

THOMSON REUTERS
·
17 Apr

Bank of America Securities Remains a Buy on BioNTech SE (BNTX)

TIPRANKS
·
17 Apr

SAP SE (0NW4): New Buy Recommendation for This Technology Giant

TIPRANKS
·
17 Apr

Novavax (NasdaqGS:NVAX) Study Shows Reduced Symptoms With New COVID-19 Vaccine Formula

Simply Wall St.
·
17 Apr

Abbott Labs Clocks Q1 Profit Beat, CEO Says Diversification And Execution Enable Navigation During Uncertainty

Benzinga
·
16 Apr

GeoVax Provides Update on BARDA Project NextGen and Outlines 2025 Business Momentum

NewMediaWire
·
16 Apr

Abbott Reports First-Quarter 2025 Results and Reaffirms Full-Year Guidance

PR Newswire
·
16 Apr

Why Typhoid Trump and COVID are so similar

The Sydney Morning Herald
·
16 Apr

GeoVax received written notification from ATI to stop Phase 2 COVID-19 work

TIPRANKS
·
16 Apr

GeoVax's COVID-19 Vaccine Study Ended by Funding Agency; Shares Fall

MT Newswires Live
·
16 Apr